Dermatology Times, April 2022 (Vol. 43. No. 4)

Qualified and Nonqualified Retirement Plans: Why Many Dermatologists Should Use Both... but Don’t

April 15, 2022

“With a traditional QRP [qualified retirement plan], a participant trades today’s tax rates on their contribution for the tax rates in the future, when they withdraw the money from the plan. If rates rise, the QRP might prove not to be a good deal at all.”

Microneedling Misconceptions

April 15, 2022

“Microneedling has been touted to the consumer as a means to enhance the penetration of moisturizers, vitamins, skin-lightening ingredients, and other cosmeceuticals. Is this enhanced penetration good? It depends.”

2022: Meeting the Challenges of Advanced BCC

April 15, 2022

Now, with an increasing emphasis on multidisciplinary tumor review boards and heightened expectations for pipeline drugs, physicians have new tools for building treatment plans that may push response rates beyond the 30% range.

Drug Watch: What's Coming in the Rosacea Pipeline

March 10, 2022

Dermatology Times® interviews editorial board member Richard Gallo, MD, PhD, who dives into what is currently lacking is rosacea patient care, how the new mechanisms of action of these potential treatments will better address current struggles, and more.

Androgenetic Alopecia Study Reveals Unmet Treatment Needs

January 26, 2022

A poster presentation from Follica at the 2022 Winter Clinical Dermatology Conference and 2022 Maui Derm for Dermatology meeting found that 56% of survey responders did not seek treatment for their hair loss, and that 19% of respondents who attempted treatment quit because of lack of efficacy or cost.